ArticleMolecular pharmaceutics2017

Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model.

Johannes M Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.